ABBEY KRAHL: Open Payments
NPI 1598089419 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 20 payments from 8 companies in 2025. Trend: 2023 $408 · 2024 $449 · 2025 $444
Food & beverage: $354Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $260 |
| Organon LLC | 3 | $43 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $42 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Abbott Laboratories | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| PFIZER INC. | 1 | $14 |
Products named: Veozah, NEXPLANON, MYFEMBREE, FREESTYLE LIBRE 3, Lynkuet, UNITHROID, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
